Close

Gen-Probe (GPRO) volatility elevated after on sharp sell off

June 7, 2011 10:51 AM EDT
Gen-Probe (Nasdaq: GPRO) Madison Williams maintains their Accumulate rating buy lower their price target to $85 from $90 following the shares selling off on June 6th WSJ headlines that said Novartis (NYSE: NVS) appears to be the last remaining bidder for Gen-Probe and it may still walk away from a potential acquisition. Overall option implied volatility of 42 is above its six-month average of 27 according to Track Data, suggesting larger price movement.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Options

Related Entities

Options